Literature DB >> 15994802

Defective replication in human immunodeficiency virus type 1 when non-primers are used for reverse transcription.

Min Wei1, Shan Cen, Meijuan Niu, Fei Guo, Lawrence Kleiman.   

Abstract

tRNA(3Lys), the primer for reverse transcriptase in human immunodeficiency virus type 1 (HIV-1), anneals to the primer binding site (PBS) in HIV-1 RNA. It has been shown that altering the PBS and U5 regions upstream of the PBS in HIV-1 so as to be complementary to sequences in tRNA(Met) or tRNA(His) will allow these tRNA species to be stably used as primers for reverse transcription. We have examined the replication of these mutant viruses in Sup-T1 cells. When Sup-T1 cells are infected by cocultivation with HIV-1-transfected 293T cells, viruses using tRNA(His) or tRNA(Met) are produced at rates that are approximately 1/10 or 1/100, respectively, of rates for wild-type virions that use tRNA(3Lys). When Sup-T1 cells are directly infected with equal amounts of these different viruses isolated from the culture supernatant of transfected 293T cells, virions using tRNA(Met) are produced at 1/100 the rate of wild-type viruses, and production of virions using tRNA(His) is not detected. Both wild-type and mutant virions selectively package tRNA(Lys) only, and examination of the ability of total viral RNA to prime reverse transcription in vitro indicates a >80% reduction in the annealing of tRNA(His) or tRNA(Met) to the mutant viral RNAs. PCR analysis of which of the three primer tRNAs is used indicates that only tRNA(3Lys) is detected as primer in wild-type virions and only tRNA(His) is detected as primer in virions containing a PBS complementary to tRNA(His), while the mutant viruses containing a PBS complementary to tRNA(Met) use both tRNA(Met) and tRNA(1,2Lys) as primer tRNAs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994802      PMCID: PMC1168737          DOI: 10.1128/JVI.79.14.9081-9087.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.

Authors:  X Li; J Mak; E J Arts; Z Gu; L Kleiman; M A Wainberg; M A Parniak
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

2.  Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).

Authors:  J K Wakefield; S M Kang; C D Morrow
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

3.  Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer).

Authors:  C Isel; C Ehresmann; G Keith; B Ehresmann; R Marquet
Journal:  J Mol Biol       Date:  1995-03-24       Impact factor: 5.469

4.  Initiation of HIV-1 reverse transcription is regulated by a primer activation signal.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

5.  Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1.

Authors:  Y Huang; J Mak; Q Cao; Z Li; M A Wainberg; L Kleiman
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).

Authors:  J K Wakefield; A G Wolf; C D Morrow
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys).

Authors:  A T Das; B Klaver; B Berkhout
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Replication of avian sarcoma virus in vivo requires an interaction between the viral RNA and the TpsiC loop of the tRNA(Trp) primer.

Authors:  Shannon Morris; Michael Johnson; Ed Stavnezer; Jonathan Leis
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Effect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity.

Authors:  Juliana Gabor; Shan Cen; Hassan Javanbakht; Meijuan Niu; Lawrence Kleiman
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys.

Authors:  C Isel; J M Lanchy; S F Le Grice; C Ehresmann; B Ehresmann; R Marquet
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

View more
  7 in total

1.  Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA.

Authors:  Li Xing; Chen Liang; Lawrence Kleiman
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

2.  Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli formula supplied in trans.

Authors:  Anna McCulley; Casey D Morrow
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome.

Authors:  Snehlata Tripathi; Binay Chaubey; Beverly E Barton; Virendra N Pandey
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

4.  Profiling non-lysyl tRNAs in HIV-1.

Authors:  Mariana Pavon-Eternod; Min Wei; Tao Pan; Lawrence Kleiman
Journal:  RNA       Date:  2009-12-09       Impact factor: 4.942

5.  Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.

Authors:  Min Wei; Yiliang Yang; Meijuan Niu; Laurie Desfosse; Robert Kennedy; Karin Musier-Forsyth; Lawrence Kleiman
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

6.  Export of Precursor tRNAIle from the Nucleus to the Cytoplasm in Human Cells.

Authors:  Min Wei; Xia Zhao; Mi Liu; Meijuan Niu; Elias Seif; Lawrence Kleiman
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

7.  Overexpressed coiled-coil domain containing protein 8 (CCDC8) mediates newly synthesized HIV-1 Gag lysosomal degradation.

Authors:  Xiangxiang Jiang; Xiaopeng Jia; Jinhuan Sun; Chunxia Qi; Lingling Lu; Yanfeng Wang; Lei Zhang; Min Wei
Journal:  Sci Rep       Date:  2020-07-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.